BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2020 9:59:39 AM | Browse: 730 | Download: 2396
 |
Received |
|
2020-05-17 12:39 |
|
Peer-Review Started |
|
2020-05-17 12:40 |
|
First Decision by Editorial Office Director |
|
2020-07-25 05:21 |
|
Return for Revision |
|
2020-07-25 05:21 |
|
Revised |
|
2020-07-29 11:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-08-31 11:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-08-31 20:09 |
|
Articles in Press |
|
2020-08-31 20:09 |
|
Edit the Manuscript by Language Editor |
|
2020-09-08 15:01 |
|
Typeset the Manuscript |
|
2020-10-21 07:52 |
|
Publish the Manuscript Online |
|
2020-10-26 09:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Mycology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guo-Jie Teng, Xiang-Rong Bai, Lin Zhang, Hong-Jun Liu and Xiu-Hong Nie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiu-Hong Nie, PhD, Chief Doctor, Department of Pulmonary and Critical Care Medicine, Xuanwu Hospital Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. xiuhongnie@126.com |
| Key Words |
Voriconazole; Hepatotoxicity; Chronic pulmonary aspergillosis; CYP2C19 genotypes; Reduction; Trough concentration |
| Core Tip |
In this retrospective study, we evaluated 12 adult chronic pulmonary aspergillosis patients who developed hepatotoxicity during voriconazole treatment. The hepatotoxicity is mainly manifested in a significant increase in the level of gamma-glutamyltransferase. In some patients, gamma-glutamyltransferase can reach up to 6-20 times to the upper limit. Overall findings recommend that reducing the lower limit of the voriconazole trough concentration to 0.5 µg/mL, can alleviate the hepatotoxicity of chronic pulmonary aspergillosis patients, and maintain the clinical efficacy. |
| Publish Date |
2020-10-26 09:59 |
| Citation |
Teng GJ, Bai XR, Zhang L, Liu HJ, Nie XH. Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole. World J Clin Cases 2020; 8(20): 4700-4707 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i20/4700.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i20.4700 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
